Friday, August 31, 2018 8:35:53 PM
DOVER, DE 6/23/2015
"Metatron Inc. a leader in mobile application development announced that it has completed a 1:10000 reverse split of its common stock Approved by FINRA it was announced June 23rd 2015 on their Daily List. This corporate action will take effect at the open of business 6/24/2015. The new symbol will be MRNJD. The “D” will be removed in 20 business days and the symbol will revert back to MRNJ. Fractional shares will be rounded up."
---
Historical quote for: MRNJ
Tuesday, January 31, 2017
Closing price: $0.0078
Open: $0.0078
High: $0.0078
Low: $0.0078
Volume: 1.93M
Unadjusted price: $0.0001
Adjustment factor: 0.0128
http://www.marketwatch.com/investing/stock/mrnj/historical
---
DOVER, DE / ACCESSWIRE / February 1, 2017 / Metatron, Inc. (OTC PINK: MRNJ) announced today a reverse stock split of its common stock, par value $0.00001 per share (the "Common Stock"), at a ratio of one-for-seventy- eight (1:78).
---
August 31, 2018
IHub-MRNJ Quote
Last Trade Time
14:02:38
Stock Price
$0.0001
---
$0.0078 >>> $0.0001
(98.7%)
---
OTCMarkets
MRNJ
Publish Date
08/13/2018
Officers and Directors
Ralph Joseph (Joe) Riehl
Chief Executive Officer (CEO), President, Secretary and Director
Denis Sluka
Chief Operating Officer (COO) and Director
Recent MRNJ News
- Metatron Apps Unveils "Dr. AI" Health Assistant for Personalized Health Support • InvestorsHub NewsWire • 01/23/2024 01:23:40 PM
- Metatron Pioneers AI-driven Content Discovery and Issues Reverse Split Moratorium • InvestorsHub NewsWire • 12/12/2023 04:59:50 PM
- Alternative to AI-Powered Apps As ChatGPT Pauses Signups • AllPennyStocks.com • 11/20/2023 03:00:00 PM
- Alternative to AI-Powered Apps As ChatGPT Pauses Signups • AllPennyStocks.com • 11/20/2023 03:00:00 PM
- Firm Pioneers AI-Powered App with Real-Time Stock Insights • AllPennyStocks.com • 10/30/2023 06:30:00 PM
- Company Looks to Revolutionze Legal Communication with AI • AllPennyStocks.com • 09/25/2023 04:50:00 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM